Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1 | 38 | 121 | N/A | N/A |
| Receivables | 86 | 21 | 137 | N/A | N/A |
| TOTAL | $87 | $59 | $258 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 575 | 743 | 739 | N/A | N/A |
| Other Non-Current Assets | 95 | 73 | 84 | 0 | 0 |
| TOTAL | $670 | $816 | $823 | $N/A | $N/A |
| Total Assets | $757 | $875 | $1,083 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 370 | 443 | 1,341 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,018 | 2,416 | 1,887 | 0 | 0 |
| TOTAL | $2,388 | $2,859 | $3,228 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 200 | N/A | N/A |
| Other Non-Current Liabilities | 112 | 92 | 83 | 0 | 0 |
| TOTAL | $112 | $92 | $283 | $N/A | $N/A |
| Total Liabilities | $2,500 | $2,951 | $3,511 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 390 | 246 | N/A | N/A | N/A |
| Common Shares | 4 | 3 | 2 | N/A | N/A |
| Retained earnings | -37,741 | -35,960 | -32,488 | N/A | N/A |
| TOTAL | $-1,743 | $-2,076 | $-2,428 | $N/A | $N/A |
| Total Liabilities And Equity | $757 | $875 | $1,083 | $0 | $0 |